Food And Drug Administration-Acorda Therapeutics-Multiple Sclerosis-Biogen Idec Inc

FDA warns about seizures with MS drug Ampyra

WASHINGTON (Reuters) - The U.S. Food And Drug Administration on Monday said people who take the multiple sclerosis drug Ampyra, from Biogen Idec Inc and Acorda Therapeutics Inc, have a higher risk of seizures when starting the treatment. The FDA also updated the label for Ampyra, which is approved to help MS patients walk, to warn about the need to check kidney function before people start taking it, and every year after that. (Reporting by Anna Yukhananov; Editing by Maureen Bavdek) read more..

source:http://yhoo.it/Osb8wp

Food And Drug Administration-Appetite Suppressant-Poor Substitute-Anticonvulsant

Qnexa Anti-Obesity Drug a Poor Substitute for Diet, Exercise

COMMENTARY | The Food And Drug Administration has approved the anti-obesity drug Qnexa for Weight Loss. Qnexa, an anticonvulsant plus appetite suppressant cocktail, has risks, says the LA Times. The FDA says being fat is a bigger threat to health than those issues, though. read more..

source:http://yhoo.it/xNyR0W

Food And Drug Administration-Hundreds Of Thousands-Health Authorities-Breast Implant

Insight: FDA warned PIP on breast implant safety

Plastic surgeon Boucq displays a silicone gel breast implant manufactured by French company Poly Implant Prothese (PIP) in a clinic in Nice

WASHINGTON (Reuters) - As early as 2000, U.S. health authorities raised concerns about the French breast implant maker at the heart of a scandal affecting hundreds of thousands of women worldwide. That was almost ten years before the company came under scrutiny from European regulators. The Food and Drug Administration sent an investigator to inspect a plant run by the manufacturer, Poly Implant Prothese (PIP), at La Seyne Sur Mer in southeastern France in May 2000. ... read more..

source:http://yhoo.it/vNHgT1